Medical Terminology in PT, BR and AO Portuguese: Key Differences

Portuguese is spoken across three continents, but a physician in Lisbon, a pharmacist in São Paulo, and a nurse in Luanda do not always use the same words to describe the same procedure or medicine. In medical translation, that difference is not just stylistic: it can affect the clarity of a package insert, the interpretation of a clinical protocol, or patient safety.

Why terminology varies across Portuguese variants

The three main variants of Portuguese developed in distinct historical, academic, and regulatory contexts. Portugal aligned closely with the European Latin tradition and adopted nomenclature consistent with European pharmacology and EMA (European Medicines Agency) guidelines. Brazil built its own healthcare system, with terminology regulated by ANVISA and shaped by conventions established in Brazilian medical schools. Angola inherited the structure of the Portuguese colonial system but was subsequently influenced by decades of international health cooperation, resulting in a mixture of European Portuguese terms, Brazilian usage, and, in some contexts, Anglophone influence.

The practical consequence is that the same clinical concept can have three different designations, all correct within their own context, but potentially confusing when applied outside it.

Concrete examples of terminological divergence

Some examples illustrate the practical dimension of this issue:

• Tablet terminology: In PT-PT, there is a clear distinction between "comprimido" (a pressed solid dosage form) and "cápsula" (a gelatine shell). In PT-BR, "cápsula" is sometimes used more broadly, and "pastilha" is common for oral dissolving forms. In Angola, both conventions coexist depending on the clinical context and the origin of the source document.
• Hospitalisation: Portugal uses "internamento hospitalar"; Brazil uses "internação". Both describe the same clinical act, but the difference surfaces in discharge records, clinical reports, and informed consent documents.
• Medicine, remedy, drug: "Medicamento" is the technical term in PT-PT for any substance with a registered therapeutic indication. "Remédio" is colloquial in Portugal but appears frequently in Brazilian clinical texts. "Fármaco" refers to the active substance and is used in technical contexts across all three variants, though with differing frequency.
• Prescription and the document: In PT-PT, "prescrição" is the medical act and "receita" is the physical document. In PT-BR, the two terms are used more interchangeably in clinical documents.
• Emergency services: PT-PT uses "urgência" for the hospital's unscheduled care department. PT-BR uses "pronto-socorro" or "UPA" (Unidade de Pronto Atendimento). In Angola, "emergência" is common, partly due to the influence of international health organisations.
• Stroke: This is a case of relative consensus. The technical term "Acidente Vascular Cerebral" (AVC) is widely shared across the three variants, though in PT-BR the informal term "derrame cerebral" still appears in public communication.

Implications for translating and localising medical documents

Choosing the correct variant has direct consequences across many document types. A package insert approved by Infarmed in Portugal cannot be used directly in Brazil without adaptation, not only for regulatory reasons but because the terminology and formatting conventions differ. A clinical trial protocol drafted for ANVISA submission must reflect the vocabulary that Brazilian investigators recognise. A medical device manual for Angolan hospitals must anticipate which terms local users are most familiar with.

Beyond terminology, there are differences in dosage abbreviations. PT-PT uses "s.o.s." (si opus sit) for as-needed medication; PT-BR more commonly spells it out as "se necessário" or uses the abbreviation "SN". These variations appear in prescriptions, medication records, and nursing instructions.

For projects involving drug labelling translation, identifying the target variant before any terminology work begins is a non-negotiable first step.

Managing terminological variation in a medical translation project

The most effective approach starts before translation begins. It requires explicitly defining the target variant, building or reviewing a specialised glossary for that variant, and ensuring that reviewers have direct experience in the corresponding region. A translator with clinical training in Portugal and no exposure to the Brazilian healthcare system can produce a technically accurate text that is still lexically misaligned with the target market.

Glossaries should also distinguish between technical terms intended for healthcare professionals and patient-facing language used in package inserts, information leaflets, and informed consent documents. A cardiologist and a patient do not process the same language, and that distinction overlaps with the differences between variants.

M21Global works on pharmaceutical and medical translation across all three Portuguese-speaking markets, with teams familiar with the specific regulatory requirements of Portugal, Brazil, and Angola. For projects that require rigorous terminological consistency across variants, the team can help map divergences and build glossaries tailored to the target market.

Related Services

Request a free medical translation quote

• Request a free medical translation quote
• Medical Device Documentation Translation Mdr Compliance
• Translating Clinical Trial Protocols Regulatory Submission
• Drug Labeling Translation

Frequently Asked Questions